These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9851956)

  • 1. Modulation by dietary salt of verapamil disposition in humans.
    Darbar D; Fromm MF; Dell'Orto S; Kim RB; Kroemer HK; Eichelbaum M; Roden DM
    Circulation; 1998 Dec; 98(24):2702-8. PubMed ID: 9851956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary salt does not influence the disposition of verapamil enantiomers in relation to efflux transporter ABCB1 genetic polymorphism in healthy Korean subjects.
    Pan W; Ryu JY; Shon JH; Song IS; Liu KH; Sunwoo YE; Kang W; Shin JG
    Xenobiotica; 2008 Apr; 38(4):422-34. PubMed ID: 18340565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary salt increases first-pass elimination of oral quinidine.
    Darbar D; Dell'Orto S; Mörike K; Wilkinson GR; Roden DM
    Clin Pharmacol Ther; 1997 Mar; 61(3):292-300. PubMed ID: 9084454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.
    Karim A; Piergies A
    Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronopharmacology of intravenous and oral modified release verapamil.
    Dilger K; Eckhardt K; Hofmann U; Kucher K; Mikus G; Eichelbaum M
    Br J Clin Pharmacol; 1999 Apr; 47(4):413-9. PubMed ID: 10233206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetics and electrocardiographic effects of intravenous verapamil with intravenous calcium chloride pretreatment in normal subjects.
    Schoen MD; Parker RB; Hoon TJ; Hariman RJ; Bauman JL; Beckman KJ
    Am J Cardiol; 1991 Feb; 67(4):300-4. PubMed ID: 1990794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.
    Fromm MF; Dilger K; Busse D; Kroemer HK; Eichelbaum M; Klotz U
    Br J Clin Pharmacol; 1998 Mar; 45(3):247-55. PubMed ID: 9517368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of racemic verapamil in patients with impaired renal function.
    Zachariah PK; Moyer TP; Theobald HM; Frantz RP; Kurtz SB; McCarthy JT; Smith RL
    J Clin Pharmacol; 1991 Jan; 31(1):45-53. PubMed ID: 2045528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenous and oral verapamil dosing.
    Reiter MJ; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1982 Dec; 32(6):711-20. PubMed ID: 7140136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Abernethy DR; Wainer IW; Anacleto AI
    Drug Metab Dispos; 2000 Jul; 28(7):760-5. PubMed ID: 10859149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.
    Keech AC; Harper RW; Harrison PM; Pitt A; McLean AJ
    Eur J Clin Pharmacol; 1988; 35(4):363-6. PubMed ID: 3197744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
    Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
    Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.